Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
4.820
+0.320 (7.11%)
At close: Aug 22, 2025, 4:00 PM
4.890
+0.070 (1.45%)
After-hours: Aug 22, 2025, 6:07 PM EDT

Monte Rosa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
298426283368950-
Upgrade
Market Cap Growth
21.32%50.74%-23.21%-61.22%--
Upgrade
Enterprise Value
48228151142583-
Upgrade
Last Close Price
4.826.945.657.6120.42-
Upgrade
PS Ratio
2.225.64----
Upgrade
PB Ratio
1.111.911.581.362.73-
Upgrade
P/TBV Ratio
1.111.911.581.362.73-
Upgrade
P/FCF Ratio
12.4811.22----
Upgrade
P/OCF Ratio
10.7410.15----
Upgrade
EV/Sales Ratio
0.273.01----
Upgrade
EV/FCF Ratio
2.026.00----
Upgrade
Debt / Equity Ratio
0.150.190.260.17--
Upgrade
Debt / FCF Ratio
1.721.12----
Upgrade
Asset Turnover
0.510.20----
Upgrade
Quick Ratio
7.002.375.0010.5820.801.43
Upgrade
Current Ratio
7.162.405.0710.7920.961.49
Upgrade
Return on Equity (ROE)
9.81%-36.15%-60.07%-35.06%-40.35%-277.72%
Upgrade
Return on Assets (ROA)
2.66%-13.66%-27.72%-19.82%-21.92%-57.90%
Upgrade
Return on Capital (ROIC)
3.23%-20.65%-32.95%-21.09%-24.85%-131.69%
Upgrade
Earnings Yield
8.12%-17.05%-47.85%-29.46%-7.79%-
Upgrade
FCF Yield
8.01%8.91%-22.22%-28.61%-7.28%-
Upgrade
Buyback Yield / Dilution
-38.55%-43.80%-8.83%-88.91%-1548.09%-7.11%
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q